🇦🇺 Australia Country × Condition
acute myeloid leukemia Clinical Trials in Australia
Active clinical trials for acute myeloid leukemia with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Enrollment
130 pts
Country
🇦🇺 Australia
PedAL BCU, LLC
View Trial → NCT05659732 Phase 1
Recruiting
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Enrollment
32 pts
Country
🇦🇺 Australia
PharmaEngine
View Trial → NCT07306832 Phase 1
Recruiting
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
18 pts
Country
🇦🇺 Australia
AbbVie
View Trial → NCT04771130 Phase 1, Phase 2
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Enrollment
260 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Australia?
There are currently 4 active clinical trials for acute myeloid leukemia with sites in Australia, of which 4 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Australia?
To join a acute myeloid leukemia clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Australia?
Active acute myeloid leukemia trials in Australia span Phase 3, Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology